Profound Medical Corp
TSX:PRN
Profound Medical Corp
Common Stock
Profound Medical Corp
Common Stock Peer Comparison
Competitive Common Stock Analysis
Latest Figures & CAGR of Competitors
Company | Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Profound Medical Corp
TSX:PRN
|
Common Stock
$232.8m
|
CAGR 3-Years
3%
|
CAGR 5-Years
21%
|
CAGR 10-Years
N/A
|
|
Neovasc Inc
TSX:NVCN
|
Common Stock
$441.4m
|
CAGR 3-Years
10%
|
CAGR 5-Years
21%
|
CAGR 10-Years
20%
|
|
Opsens Inc
TSX:OPS
|
Common Stock
CA$97m
|
CAGR 3-Years
21%
|
CAGR 5-Years
12%
|
CAGR 10-Years
20%
|
|
Nanalysis Scientific Corp
XTSX:NSCI
|
Common Stock
CA$53.2m
|
CAGR 3-Years
37%
|
CAGR 5-Years
40%
|
CAGR 10-Years
N/A
|
|
Theralase Technologies Inc
XTSX:TLT
|
Common Stock
CA$47.2m
|
CAGR 3-Years
4%
|
CAGR 5-Years
10%
|
CAGR 10-Years
17%
|
|
MedMira Inc
XTSX:MIR
|
Common Stock
CA$68.7m
|
CAGR 3-Years
3%
|
CAGR 5-Years
2%
|
CAGR 10-Years
2%
|
See Also
What is Profound Medical Corp's Common Stock?
Common Stock
232.8m
USD
Based on the financial report for Mar 31, 2024, Profound Medical Corp's Common Stock amounts to 232.8m USD.
What is Profound Medical Corp's Common Stock growth rate?
Common Stock CAGR 5Y
21%
Over the last year, the Common Stock growth was 11%. The average annual Common Stock growth rates for Profound Medical Corp have been 3% over the past three years , 21% over the past five years .